Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chloramphenicol and tetracyclines.

E L Francke1, H C Neu

  • 1University of Minnesota Medical School, Minneapolis.

The Medical Clinics of North America
|November 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gemfibrozil enhances the listeriacidal effects of fluoroquinolone antibiotics in J774 macrophages.

The Journal of experimental medicine·1992
Same author

In vitro activity of CP-74,667. A new fluoroquinolone compared with other quinolones.

Diagnostic microbiology and infectious disease·1992
Same author

Plasma bactericidal activity of a new C-5 methyl fluoroquinolone after oral doses of 400 and 800 mg.

Journal of clinical pharmacology·1992
Same author

The crisis in antibiotic resistance.

Science (New York, N.Y.)·1992
Same author

In vitro activity of MC-352, a new 16-membered macrolide.

Antimicrobial agents and chemotherapy·1992
Same author

The activity of metal compounds against aerobic and anaerobic bacteria.

Diagnostic microbiology and infectious disease·1992
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Tetracyclines offer broad-spectrum antimicrobial activity, remaining crucial for specific infections like those caused by Chlamydiae and Rickettsiae. Doxycycline improves tolerability, though phototoxicity remains a concern.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Internal Medicine

Background:

  • Tetracyclines possess broad-spectrum antimicrobial properties, valuable in clinical practice.
  • While alternatives exist for common infections, tetracyclines are essential for specific pathogens like Chlamydiae, Rickettsiae, Brucella, and Borrelia.

Purpose of the Study:

  • To review the clinical utility and specific applications of tetracycline antibiotics.
  • To highlight the advantages and limitations of doxycycline and other tetracycline derivatives.

Main Methods:

  • Literature review of tetracycline pharmacology and clinical applications.
  • Analysis of therapeutic uses in various infectious and non-infectious conditions.

Main Results:

Related Experiment Videos

  • Tetracyclines are first-line agents for infections caused by Chlamydiae, Rickettsiae, Brucella, and Borrelia.
  • Doxycycline offers improved gastrointestinal tolerance and usability in renal dysfunction compared to older tetracyclines, but presents a risk of phototoxicity.
  • Tetracycline remains useful for malignant effusions, and demeclocycline is a preferred treatment for inappropriate antidiuretic hormone secretion.

Conclusions:

  • Tetracyclines maintain significant clinical importance for specific infections and conditions.
  • Doxycycline represents an advancement in tetracycline therapy, balancing efficacy with improved tolerability, despite phototoxicity concerns.